james g. stevenson, pharm.d., bcps, fashp · curriculum vitae james g. stevenson, pharm.d. academic...

Curriculum Vitae James G. Stevenson, Pharm.D.

JAMES G. STEVENSON, PHARM.D., FASHP

Curriculum Vitae

EDUCATION

July 2003-June 2004 Healthcare Leadership Institute University of Michigan School of Business / University of Michigan Health System

November 1994 Executive Management Program in Healthcare Outcomes The University of Southern California Center of Excellence in Healthcare Management

October 1994 Executive Management Program for Directors of Hospital Pharmacy Leonard Davis Institute of Healthcare Economics The Wharton School The University of Pennsylvania

June 1990 Hospital Pharmacist Executive Management Program Duke University Fuqua School of Business

August 1980-June 1982 DOCTOR OF PHARMACY DEGREE Wayne State University College of Pharmacy and Allied Health Professions

September 1976-June 1980 BACHELOR OF SCIENCE IN PHARMACY Wayne State University College of Pharmacy and Allied Health Professions

September 1975-June 1976 Michigan State University East Lansing, Michigan (Pre-pharmacy curriculum)

mailto:[email protected]


POSITIONS HELD

September 2011-Present Chief Pharmacy Officer University of Michigan Health System

And Associate Dean and Department Chair Department of Clinical, Social, and Administrative Sciences University of Michigan College of Pharmacy

July 1999 – 2011 Director of Pharmacy Services University of Michigan Health System

And Professor and Associate Dean for Clinical Sciences University of Michigan College of Pharmacy (Tenure conferred 2010)

December 1996 – July 1999 Executive Director of Pharmacy Services The Detroit Medical Center and Professor and Academic Director Graduate Program in Health Systems Pharmacy Management College of Pharmacy and Allied Health Professions Wayne State University

September 1991-December 1996 Director of Pharmacy Services Detroit Receiving Hospital and University Health Center

Detroit, MI 48201 and Associate Professor and Academic Director Graduate Program in Health Systems Pharmacy

Management College of Pharmacy and Allied Health Professions Wayne State University

August 1989-September 1991 Director of Pharmaceutical Services West Virginia University Hospitals

July 1987-August 1989 Associate Director for Patient Care, Educational, and

Research Services Department of Pharmaceutical Services West Virginia University Hospitals

April 1985-July 1987 Assistant Director for Clinical, Educational and

Research Services Department of Pharmaceutical Services West Virginia University Hospitals

July 1982-April 1985 Assistant Professor of Clinical Pharmacy School of Pharmacy West Virginia University

August 1980-June 1982 Pharmacist Harper-Grace Hospitals, Harper Hospital Division


ACADEMIC APPOINTMENTS

Sept 2011 – Present Chair, Department of Clinical, Social, and Administrative Sciences College of Pharmacy University of Michigan

July 1999-Present Professor of Pharmacy (with tenure 2010) Associate Dean for Clinical Sciences College of Pharmacy University of Michigan

Sept 1999-Present Adjunct Professor College of Pharmacy and Allied Health Professions Wayne State University

May 1999-July 1999 Professor and Academic Director Graduate Program in Health Systems Pharmacy


September 1991-May 1999 Associate Professor and Academic Director Graduate Program in Health Systems Pharmacy


May 1994 – July 1999 Adjunct Clinical Associate Professor of Pharmacy College of Pharmacy University of Michigan April 1985-September 1991 Clinical Assistant Professor of Pharmacy School of Pharmacy West Virginia University

July 1982-April 1985 Assistant Professor of Clinical Pharmacy School of Pharmacy West Virginia University

CURRENT TEACHING RESPONSIBILITIES

University of Michigan

P550 Opportunities in Pharmacy (Guest Lecturer) P422 Health Systems (Guest Lecturer) P692 Health-System Pharmacy Administration Clerkship ASHP Research and Education Foundation’s Pharmacy Leadership Academy Lead Faculty for 6 Week On-line Module, “Leading Technology Advancement” (2011-Present)


COMMITTEE RESPONSIBILITIES

University of Michigan /University of Michigan Health System

University of Michigan Hospitals and Health Centers Senior Management Team (2009-Present) Pharmacy and Therapeutics Committee (Vice-chair, 1999-Present) Health System Clinical Quality Committee (2010-Present) Patient Safety Committee (2001-Present) College of Pharmacy Executive Committee (1999-Present) College of Pharmacy Policy Review Committee ( 2001-Present) College of Pharmacy Practitioner Relations Committee (2000-2012, Chair) University of Michigan Prescription Benefit Advisory Committee (2002-2012) University of Michigan Prescription Drug Oversight Committee (2002-2012) Continuous Quality Improvement Lead Team (2001-2010) University of Michigan Health System “Fostering Innovation Grant” Selection Committee (July 2007-2010) UM CareLink Information Management Operations Committee (September 2008- 2009) UM CareLink Information Management Operations Committee Executive Group (September 2008-2009) Vice Chair, President Coleman’s Michigan Healthy Community Initiative, University of Michigan (September 2005-January 2007) Michigan Health Community Advisory Committee, University of Michigan Office of Staff Benefits (March 2007-2010) University of Michigan Chief Health Officer Search Committee (2006) UM-CareLink (CPOE) Steering Committee (2005-2007) University of Michigan Health System Strategic Planning Committee on the Electronic Patient Care Environment (Chair, 2005-2006) Ambulatory Care Information System Steering Committee (2006-2009) HomeMed Home Health Care Operations Review Committee (1999-2003) University Advisory Committee , University of Michigan Depression Center (2002-2005) Adverse Drug Event Prevention Task Force (Co-chair, 1999-2000) Operations Improvement Council (2000 – 2004) University of Michigan Prescription Drug Benefit Workgroup (2000-2002) Chief of Nursing Services/Associate Dean Search Committee (2001)

PROFESSIONAL SERVICE

St. Jude’s Children’s Research Hospital, External Review Committee for the Department of Pharmaceutical Sciences (July 2013) Michigan Board of Pharmacy, Appointed by Governor Snyder, (July 2012-Present) United States Pharmacopeia (USP) Convention Member, (2010-Present) International Pharmaceutical Federation (FIP) - Pharmabridge Program–USA/ Hospital Section Representative to Steering Committee (2006-Present) - Treasurer, Hospital Pharmacy Section (2010-Present) - Board of Pharmacy Practice Member (2010-Present) - Development Committee, Global Conference on the Future of Hospital Pharmacy (2007) Center for Healthcare Research and Transformation(CHRT), Expert Advisor (20011- Present) University Health-System Consortium (UHC), Strategic Initiatives Committee (2000-Present) Great Lakes Pharmacy Residency Conference, Steering Committee (Michigan representative), (2004-Present) American Society of Health-System Pharmacists (ASHP)

- Survey Panel for the Pharmacy Forecast 2014-2018, ASHP Foundation’s Center for Health-System Pharmacy Leadership


- Ambulatory Care Practice Model Summit Advisory Group, (April 2013-Present) - Task Force on Pharmacy in Accountable Care Organizations, (Chair, June 2012-Present) - Board of Directors (2007-2010) - Section of Practice Managers, Executive Committee Director at Large (2005-2006) - ASHP Foundation Development Committee (2004- 2009) - ASHP/ACPE Joint Task Force on Competencies for Entry to Hospital and Health-system Practice

(2009-2010) - CEO/Executive Vice President Search Committee (Vice-chair, 2009-2011) - House of Delegates Member representing Michigan (2005-2007) - Council on Educational Affairs, 2003-Present (Vice chair 2004-2005, Chair 2005-2006)

Joint Commission on the Accreditation of Healthcare Organizations, - Joint Commission International Center for Patient Safety, Medication Safety Advisory Group (2006-

2008) - Advisory Panel, The Joint Commission’s 21st Annual National Conference on Quality and Safety;

(2007) International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

- Internet Education Task Force Steering Committee (2003-2006) American College of Clinical Pharmacy (ACCP)

- Public and Professional Relations Committee (2002-2003) - Task Force on Measuring Clinical Pharmacists’ Productivity, ACCP (2000-2002) - Committee on Postdoctoral Training in Pharmacoeconomic Research (1996-1999)

American Pharmacists Association, Member (1982-Present) American Association of Colleges of Pharmacy (1983-Present) Premier Purchasing Partners, Formulary Advisory Panel (1999) Selectcare, Troy Michigan, Pharmacy and Therapeutics Committee, (1999-2001) Board of Directors, Southeastern Michigan Society of Health-system Pharmacists (1994-1998) Michigan Society of Health-System Pharmacists (MSHP)

- Board of Directors (1996-1997, 2003-2005) - Organizational Affairs Committee (1998-1999) - Educational Affairs Committee (2000-2003)

Southeastern Michigan Society of Health-System Pharmacists (SMSHP) - Program and Seminar Committee (Chairman, (1993-1994) - Professional/Legal/Public Affairs Committee (1992-1993)

West Virginia Pharmacists Association - Continuing Education Committee (Chairman (1984-1987) - Board of Directors (1985- 1991)

West Virginia Society of Hospital Pharmacists - Continuing Education Committee (1988-1990) - President (1991)

Eastern States Region Hospital Pharmacy Residency Conference, Advisory Committee (1988-1989; 1990-1991) State of West Virginia

- Prescription Program Administrator Selection Committee, Public Employees Insurance Administration(1990)

BOARD MEMBERSHIP

Board of Directors, CDEX, Inc., Tucson, AZ (2010-Present) University Advisory Board for the University of Michigan Depression Center (2002-2006) Advisory Board, Pharmacy Technician Training Institute, Detroit, MI (1997-1999) Institutional Review Board for the Protection of Human Subjects, West Virginia University (1990-1991) Board of Directors (Secretary), Allied Health Services and Pharmacy, Inc. (1989-1991)


HONORS AND AWARDS

Rho Chi Pharmacy Honor Society (1981) Roche Hospital Pharmacy Research Grant Recipient (1981) Bristol Award, Wayne State University (1982) Award for Original Research, Eighth Annual Midwestern Conference of Residents, University of Nebraska Medical Center, May (1982) Best Poster: Research in Psychopharmacy Practice: Pupillometry and the Effect of Tranylcypromine on Muscarinic and Alpha- Adrenergic Receptor Sensitivity in Depressed Patients, ASHP Midyear Clinical Meeting (1982) Lenard Gottleib Pharmacy Research Award, West Virginia University (1984) Syntex Preceptor of the Year Award, West Virginia University School of Pharmacy (1987) Fellow of the American Society of Health-system Pharmacists (FASHP) (1993) Board Certified Pharmacotherapy Specialist (BCPS) (1994-2001) Bristol-Myers Squibb Pharmacy Leadership Award (1997) Wayne State University College of Pharmacy Distinguished Alumnus Award (1998) Pharmacist of the Year, Michigan Society of Health-System Pharmacists (1998) Frances Rhoades Medal, Wayne County Medical Society (2003) Joseph A. Oddis Leadership Award, Michigan Society of Health-System Pharmacists (2007) Pharmacist of the Year Award, Michigan Pharmacists Association (2009) ASHP Research and Education Foundation, Pharmacy Practice Research Award for Outstanding Contribution to the Research Literature Related to Pharmacy Practice in Health Systems. Kaakeh Y, Phan H, DeSmet B, Pasko DA, Glenn DK, Stevenson JG. Enhanced photoemission spectroscopy for verification of high-risk i.v. medications. Am J Health-Syst Pharm 2008; 65:49-54. (2009)010 Researcher in International Exchange Program sponsored by the Japanese Society of Hospital Pharmacists and the Japanese Ministry of Health, Labour, and Welfare on the theme "Studies of the Methods of Pharmaceutical Activity in Japanese Hospitals and Their Evaluation". Included lectures and visits to:

Kyushu University Hospital

Kyushu National Cancer Center

Kagoshima University Hospital

Saiseikai Yokohama Nannbu Hospital

Tokyo University Hospital

John W. Webb Lecture Award, American Society of Health-System Pharmacists (ASHP) and the Bouve’ College of Pharmacy, Northeastern University (2010) Honorary Resident, University of Wisconsin Hospitals and Clinics, Pharmacy Residency Program 50th Reunion (2013) Award for Distinguished Leadership in Health-System Pharmacy Practice. American Society of Health- System Pharmacists (ASHP) (2013) Honorary Member, Phi Lambda Sigma Pharmacy Leadership Society, University of Michigan College of Pharmacy, Delta Kappa Chapter (2014) Departmental Awards Under My Direction Computerworld/Smithsonian Institution Museum of American History, Computerworld Honors Program for outstanding IT applications – University of Michigan Health System Department of Pharmacy Services (2004) University of Michigan Business Intelligence Award for Innovation (2007) ASHP Foundation’s Residency Excellence Award – University of Michigan Health System Department of Pharmacy Services for PGY1 Residency (2010) Michigan Society of Health-System Pharmacists Innovative Practice Award – University of Michigan College of Pharmacy/Heatlh System Department of Pharmacy Services, for development of patient- centered medical home model pharmacy services (2011)


ASHP Best Practice Award for development of patient-centered medical home model pharmacy services (2011) ASHP Foundations’ Award for Excellence in Medication Safety (finalist) for work in improving safety related to pain management (2011) University of Michigan Health System, Clinical Program of the Year Award – for the UMHS Transplant Specialty Pharmacy Service (2011) PUBLIC SERVICE

CPR Instructor (BCLS), West Virginia Affiliate, American Heart Association #2064 (1989-1991) Volunteer Speaker, Poison Control Center, Children's Hospital of Michigan (1979-1982) Volunteer Speaker, West Virginia Poison System (1986-1991) Consultant Pharmacist, Sundale Nursing Home, Morgantown, WV (1982-1985) Consultant Pharmacist, Morgantown HealthRight Free Clinic, Morgantown, WV (1988-1991)

EDITORIAL ACTIVITIES

Reviewer, Oncology Practice Management, ACCP/ASHP Oncology Review and Recertification Course for the Board of Pharmaceutical Specialties (2014) Department Editor on Medication Safety, Editorial Advisory Board,. Joint Commission Journal on Quality and Patient Safety, (2004- 2013) Reviewer, American Journal of Health-system Pharmacy Reviewer, Pharmacotherapy, (2006-Present) Reviewer, American Journal of Pharmaceutical Education, (2003-Present) Reviewer, Journal of the American Medical Informatics Association, (2011-Present) Reviewer of Contributed Abstracts, American College of Clinical Pharmacy Annual Meeting, (2005-Present) Abstract Review Committee, ISPOR Annual International Meeting, (2001-2002) Contributor and Reviewer, ISPOR Lexicon Project, (2001-2002)

Contributor, ISPOR Lexicon Project, 2nd Edition (2002)

Reviewer, PSAP Module on Outcomes Assessment and Pharmacoeconomics, (2001) Reviewer, PharmacoEconomics, (1994-1999) Reviewer, Hospital Pharmacy, (1996-1999) Reviewer, DICP: The Annals of Pharmacotherapy, (1982-2002) Reviewer, Pharmat Continuing Education Pilot Project on Hypertension, (1983) Contributor, Pharmacy Facts, (1982-1985) Reviewer, West Virginia University Senate Research Grant Selection Committee, (1983-1985) Research and Education Foundation Grant Selection Committee, American Society of Hospital Pharmacists, (1985-1988) Reviewer of Contributed Papers, American Society of Hospital Pharmacists Midyear Clinical Meetings, (1985-Present) Grant Reviewer, Using Information Management Systems to Improve Clinical Practice Grant Program, WSU/DMC Center for Health Effectiveness Research, (1997) Reviewer, Abbott National Hospital Pharmacy Quality Award Program, (1999-2001) FELLOWSHIP IN PHARMACOECONOMICS AND OUTCOMES RESEARCH

Postgraduate fellowship implemented in 1995 at Wayne State University; 2001 at the University of Michigan

Fellows Directed:

Muhammad Mamdani, Pharm.D. (Wayne State University) Daniel Touchette, Pharm.D. (Wayne State University)


Jeff Ellis, Pharm.D. (University of Michigan) Brian DeSmet, Pharm.D. (University of Michigan) Rola Kaakeh, Pharm.D. (University of Michigan)

MASTER'S ESSAYS DIRECTED (Wayne State University)

VanBelle, M. Evaluation of a centralized compounding center for the St. John Health System, April 2001, (Research Advisor)

Pisani, M. A survey of antibiotic policies in hospitals., March 2001, (Research Advisor)

McDonald L. Measurement of pharmaceutical work processes in a patient focused care pilot, October 1998, (Research Committee)

Rodemeyer M. Alternatives to Full-Time Management Positions, October 1997, (Research Advisor)

Karageanes A. Improving Patient Outcomes in Pain Therapy Using Continuous Quality Improvement, September 1997 (Research Committee)

Plath W. Quality of Life Studies and the Pharmaceutical Industry, November 1996, (Research Advisor)

Joseph T. Pharmacotherapy for the Treatment of Helicobacter pylori in Peptic Ulcer Disease: A Cost-Effectiveness Analysis , February 1996, (Research Advisor)

Liskiewicz J. Cost Justification of an Operating Room Pharmacy Technician, February 1996, (Research Advisor)

Nastwold, S. Application of Total Quality Management (TQM) to the Delivery of Pharmaceuticals in a Patient Focused Care Unit, February 1995, (Research Committee)

Ragatzki, M. Application of Total Quality Management (TQM) to the IV Admixture Process, February 1995 (Research System Committee)

Fernet, M. Pharmaceutical Service Representatives: A Survey of Their Attitudes Toward Pharmaceutical Marketing Practices, October 1994 (Research Committee)

Meier C. Assessing the impact of computerizing clinical interventions, cost savings and workload documentation, September 1994 (Research Advisor)

Carney L. Effectiveness of a System for Documenting Allergy Histories in Hospitalized Patients, February 1993, (Research Advisor)

Sekmistrz P. Assessing the Utilization of Electronic Infusion Devices at a Private Community Teaching Facility, February 1993, (Research Committee).

Rutkowski D. Development and Justification of Decentralized Pharmacy Services for Emergency Center Patients, February 1993, (Research Committee).

Gill G. Cost Effectiveness of Converting from Intravenous Ranitidine to Oral or Nasogastric Therapy, November 1990, (Research Advisor)


PhD Candidate Committee (University of Michigan)

Liu J. The implementation of a bar-code medication administration (BCMA) system and medication administration errors (MAE). (Preliminary examination committee – School of Nursing)

PUBLICATIONS

Peer Reviewed 68. Weber RJ, Stevenson JG, White S. Measuring change in health-system pharmacy over 50

years: “reflecting” on the Mirror, Part II. Hospital Pharmacy 2014; 49:97-100. 67. Weber RJ, Stevenson JG, Ng C, White S. Measuring change in health-system pharmacy over

50 years: “reflecting” on the Mirror, Part I. Hosp Pharm 2013; 48:966-969. 66. Bickel R, Collins C, Lucarotti R, Stevenson, JG, Pawlicki K, Bauman T, Pratt DM. Moving the

pharmacy practice model initiative forward within a state affiliate. Am J Health-Syst Pharm (Submitted).

65. Stevenson JG, Beham RE, Weber RJ. Profiles in leadership: Donald E. Francke, M.Sc., D.Sc.

(Hon). Hospital Pharmacy 2013; 48:778-782. 64. Wheeler NJ, DeLucia PR, Esquibel KA, Randell JA, Stevenson JG, Gage T, Zheng K. Focused

ethnographic observations: Cues to medication administration. Ergon Des (submitted). 63. Lucio S, Stevenson JG, Hoffman J. Biosimilars: Primer for the health-system pharmacist. Am J

Health-Syst Pharm 2013; 70:2004-17.. 62. Rood JM, Engels MJ, Ciarkowski SL, Wagenknecht LD, Dickinson CJ, Stevenson JG. Variability

in compounding of oral liquids for pediatric patients: A patient safety concern. J Am Pharm Assoc (manuscript accepted – in press).

61. Zheng K, Fear K, Chaffee BW, Zimmerman CR, Gatwood J, Stevenson JG, Pearlman MD. The

epidemic of alert fatigue: Is the perception of “too many alerts” an illusion or a reference of facts? J Am Med Inform Assoc (manuscript submitted)

60. Griffith N, McBride A, Stevenson JG, Green L. Formulary selection criteria for biosimilars: considerations for health-system pharmacists. Hosp Pharm (manuscript accepted – in press)

59. Woods AD, Mulherin D, Flynn AJ, Stevenson JG, Zimmerman CR, Chaffee BW. Clinical decision

support for atypical orders: detection and warning of unusual medication orders submitted to a computerized provider order entry system. J Am Med Inform Assoc Published Online First: 19 November 2013 doi:10.1136/amiajnl-2013-002008.

58. Report of the 2012 ASHP Task Force on Accountable Care Organizations (Stevenson JG, Chair).

Am J Health-Syst Pharm 2013; 70:66-76. 57. Knoer S, Weber RJ, Witmer D, Zilz D, Ashby D, Rough S, Stevenson JG, Bush PW, Daniels R,

Calabrese S, Chen D. Highlights of the Cleveland Clinic Pharmacy Practice Model Summit. Am J Health-Syst Pharm 2013; 70:356-65.


56. Choe HM, Farris KB, Stevenson JG, Townsend K, Diez HL, Remington T, Rockafellow S, Shimp LA, Sy A, Wells T, Standiford CJ. Patient centered medical home: Developing, expanding and sustaining a role for pharmacists. Am J Health-Syst Pharm 2012;69 1063-1071

55. Tran M, Ciarkowski S, Wagner D, Stevenson JG. A case study on the safety impact of

implementing smart patient-controlled analgesic pumps at a tertiary care academic medical center. Joint Commission Journal on Quality and Patient Safety 2012; 38:112-119.

54. Hlubocky J, Stucky L, Schuman A, Stevenson JG. Evaluation of a specialty pharmacy program

in solid organ transplantation. Am J Health-Syst Pharm 2012 69:340-347. 53. Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, Higgins B, Clark AM, Stevenson JG. Impact

of drug shortages on US health systems. Am J Health-Syst Pharm 2011; 68:1811-1819. 52. Stevenson JG. Overcoming inertia: Achieving more-rapid transformation of pharmacy practice.

The 2011 John W. Webb Lecture. Am J Health-Syst Pharm 2011; 68:604-612. 51. Bush PW, Ashby DM, Guharoy R, Knoer S, Rough S, Stevenson JG, Wiest M. Pharmacy

practice model for academic medical centers. Am J Health-Syst Pharm 2010;67 1856-1861 50. Zheng K, Fear K, Chaffee BW, Zimmerman CR, Karls EM, Stevenson JG, Pearlman MD.

Development and validation of a survey instrument for assessing prescribers’ perception of computerized drug-drug interaction alerts. J Am Med Inform Assoc. 2011;18(Suppl 1):51–61.

49. Chaffee BW, Armitstead JA, Benjamin BE, Cotugno MC, Forrey RA, Hintzen BL, Pfeiffenberger T, Stevenson JG. Guidelines for the safe handling of hazardous drugs: Consensus recommendations. Am J Health-Syst Pharm 2010; 67:1545-1546.

48. Nemerovski C, Mackler ER, DePestel D, Collins CD, Welch KS, Stevenson JG. Drug costs and

utilization after implementation of a posaconazole prophylaxis protocol in adults with acute myelogenous leukemia. Am J Health Syst Pharm 2010;67 295-299

47. Sy FZ, Choe HM, Kennedy DM, Standiford CJ, Parsons D, Bruhnsen K, Stevenson JG, Bernstein

SJ. Moving from a to z: successful implementation of a statin switch program by a large physician group. Am J Managed Care 2009; 15:233-240.

46. Spaulding A, Fendrick AM, Herman WH, Stevenson JG, Smith DG, Chernew ME, Parsons D,

Bruhnsen K, Rosen AB. Design and implementation of a controlled trial of targeted value-based co-payment reductions to improve adherence to evidence-based therapies in diabetes: The MHealthy – Focus on Diabetes (FOD) Trial. Implementation Sci 2009;4:19.

45. Choe HM, Bernstein SJ, Mueller BA, Walker PC, Stevenson JG, Standiford CJ. Pharmacist

leads primary care team to improve diabetes care. Am J Health-syst Pharm 2009; 66:622-624. 44. Nemerovski C, Stevenson JG. The development of clinical pharmacy practice in the United

States. Indian Journal of Hospital Pharmacy 2008;45:116-118. 43. Kaakeh Y, Phan H, DeSmet B, Pasko DA, Glenn DK, Stevenson JG. Enhanced photoemission

spectroscopy for verification of high-risk i.v. medications. Am J Health-syst Pharm 2008; 65:49-54.

42. Hatton RC, Chavez ML, Jackson E, Maurey J, Barriere SL, Couchenour R, Evans RP, Gunning

K, Hume AL, Hutchison LC, Matzke GR, Noviasky JA, Rospond RM, Shepard Kelloway J,


Stevenson JG, Vanderveen RP, Verme-Gibboney CN, Walters D. Pharmacists and industry: guidelines for ethical interactions. Pharmacotherapy 2008; 28:410-420.

41. Turck CJ, Marsh W, Stevenson JG, York JM, Miller H, Patel S. Pharmacoeconomics of surgical

interventions vs. cyclooxygenase inhibitors for the treatment of patent ductus arteriosus. J Pediatr Pharmacol Ther 2007; 12:183-193.

40. Saad, A, Sweet, B, Stumpf JL, Gruppen L, Oh M, Stevenson JG. Use of simulation testing to

assess pharmacist recognition of and adherence to medication use policies and safety practices. Am J Health-syst Pharm 2007; 64:2050-4.

39. Bahl, V, McCreadie SR, Stevenson, JG. Using dashboards to measure and manage

inpatient pharmacy costs. Am J Health-Syst Pharm 2007; 64:1859-1866. 38. Kuiper SA, McCreadie SR, Mitchell JF, Stevenson JG. Medication errors in inpatient pharmacy

operations and technologies for improvement. Am J Health-syst Pharm 2007; 64:955-59.

37. Collins CD, Stuntebeck ER, DePestel DD, Stevenson JG. Pharmacoeconomic analysis of

liposomal amphotericin B versus voriconazole for empiric treatment of febrile neutropenia. Clinical Drug Invest 2007; 27:233-241.

36. Choe, HM, Stevenson, JG, Streetman DS, Heisler M, Standiford CJ, Piette JD. The impact of

patient financial incentives on participation and outcomes in a statin pill-splitting program: results of a randomized trial. Am J Manag Care. 2007;13:298-304.

35. Stevenson JG, Natale JJ. Darbepoetin alfa: an effective and flexible treatment for anemia in

patients with cancer. Pharmacotherapy 2007; 27:434-446. 34. Mohammad RA, Mueller BA, Sweet, BV, Stevenson JG. Outcomes of an erythropoietic growth

factor interchange program in hospitalized chronic hemodialysis patients. Hosp Pharm 2007; 42:119-125.

33. Stevenson JG, Varner DL. Current issues impacting hospital pharmacy directors. Hosp Pharm

2006; 41:S11-S15. 32. DeSmet BD, Fendrick AM, Stevenson JG, Bernstein SJ. Over and under utilization of cox-2

selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited. J Gen Intern Med 2006: 21:694-697.

31. Touchette DR, Stevenson JG, Jensen G. Cost-effectiveness analysis of amifostine (Ethyol) in

patients with non-small cell lung cancer. Journal of Aging and Pharmacol 2006;13:109-126. 30. Stevenson JG, Pearlman M, Green CR, et al. Altering meperidine prescribing patterns in a

university teaching hospital. Joint Commission Journal on Quality and Safety 2004: 30:277-281. 29. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Sub-optimal statin

adherence and discontinuation in primary and secondary prevention populations. Should we target patients with the most to gain? J Gen Intern Med 2004: 19; 639-645.

28. Nau DP, Garber MC, Lipowski EE, Stevenson, JG. The relationship of hospital size with quality

improvement for pharmacy services. Am J Health-syst Pharm 2004: 61:184-189.

27. McCreadie SR, Stevenson JG, Sweet BV, Kramer M. Using personal digital assistants as a

novel approach to accessing drug information. Am J Health-Syst Pharm 2002;59:1340-3.


26. Sweet BV, Stevenson JG. Pharmacy costs associated with processing non-formulary drug requests in an inpatient setting. Am J Health-Systt Pharm 2001; 58:1746-52.

25. McCreadie SR, Stevenson JG. Use of an intranet to improve communication and manage

knowledge within a large, multi-site pharmacy department. Am J Health-Syst Pharm 2000; 57:1430-6.

24. Mamdani M, Reisig C, Stevenson JG. Cost analysis of therapeutic substitution of calcium channel

blockers for the treatment of hypertension in a VA hospital. J Managed Care Pharm 2000; 6:390-394.

23. Lee J, Lawrence BJ, Sullivan SD, Johnson NE, Barriere SL, Lake KD, Stevenson JG. ACCP Position Statement: Guidelines for pharmacoeconomic research fellowships. Pharmacotherapy 1999; 19:1105-1109.

22. Mamdani M, Racine E, McCreadie S, Zimmerman C, O’Sullivan T, Jensen G, Ragatzki P, Stevenson J. Clinical and economic evaluation of a nomogram-based inpatient anticoagulation service. Pharmacotherapy 1999;19:1064-1074.

21. Weingarten CM, Rybak MJ, Jahns BE, Stevenson JG, Levine DP. An evaluation of Acinetobacter baumannii infections and antimicrobial treatment patterns in an urban teaching hospital. Pharmacotherapy 1999;19:1080-1085.

20. Mamdani M, Stevenson JG. Drug utilization and economic profiles of patients receiving fosinopril compared to quinapril. J Applied Therapeutic Research 1998;2:39-48.

19. Zimmerman CR, Smolarek RT, Stevenson JG. Peer review and continuous quality improvement of pharmacists’ clinical interventions. Am J Health-Syst Pharm 1997; 54:1722-7.

18. Przybylski KG, Rybak MJ, Martin PR, Weingarten CM, Zaran FK, Stevenson JG, Levine DP. Pharmacist initiated IV to oral antibiotic treatment program. Pharmacotherapy 1997; 17:271-6.

17. Mamdani M, Weingarten CM, Stevenson JG. Thromboembolic prophylaxis in moderate risk patients undergoing elective abdominal surgery: decision and cost-effective analyses. Pharmacotherapy 1996; 16:1111-27.

16. Zaran FK, Weingarten CM, Rybak MJ, Stevenson JG. Effect of constructive feedback on pharmacist handling of orders for monitored antimicrobials. Am J Health-Syst Pharm 1996; 53:2196-8.

15. Loughlin KA, Weingarten CM, Nagelhout J, Stevenson JG. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room. Pharmacotherapy 1996; 16:942-50.

14. Gates DM, Smolarek RT, Stevenson JG. Outsourcing the preparation of parenteral nutrient solutions. Am J Health-Syst Pharm 1996; 53:2176-8.

13. Janning S, Stevenson JG, Smolarek RT. Implementing comprehensive pharmaceutical services at an academic tertiary care hospital. Am J Health-System Pharm 1996; 53:542-7.

12. James JK, Stevenson JG, Smolarek RT. Pharmacy preparation of total nutrient admixtures. Am J Health-System Pharm 1995; 52:2727-8.

11. Zimmerman CR, Smolarek RT, Stevenson JG. A computerized system to improve documentation and reporting of pharmacists' clinical interventions, cost savings, and workload activities. Pharmacotherapy 1995; 15:220-7.


10. Stevenson JG, Chideckel EW. Evaluation of cilazapril (Inhibace) versus captopril in patients with mild to moderate essential hypertension. Clinical and Experimental Hypertension 1994; 16:179-196.

9. Stevenson JG, Bakst C, Zaran FK, Rybak MJ, Smolarek RT, Alexander MR. Quality improvement in the use of medications through a drug use evaluation service. Topics in Hosp Pharm Management 1992; 12(3):47-56.

8. D'Angio RG, Stevenson JG, Lively BT, Morgan JE. Therapeutic drug monitoring: Improved performance through educational intervention. Ther Drug Monitoring 1990; 12:173-181.

7. Woodward CT, Stevenson JG, Poremba A. Assessing the quality of pharmacist answers to telephone drug information questions. Am J Hosp Pharm 1990; 47:798-99.

6. Poremba A, Stevenson JG. Pharmacy rounds: A cost containment tool. Topics in Hosp Pharm Management 1988; 8:22-29.

5. Stevenson JG, Patriarca C. Incompatibility of morphine sulfate and prochlorperazine edisylate in syringes. Am J Hosp Pharm 1985; 42:2651.

4. Stevenson JG. Formulary management: Gaining physician support of a closed formulary. Hosp Formulary 1985; 20:1105.

3. Stevenson JG, Umstead GS. Sexual dysfunction due to antihypertensive agents. Drug Intell Clin Pharm 1984; 18:113-121.

2. Sitaram N, Jones D, Kelwala S, Bell J, Stevenson J, Gershon S. Pharmacology of the human iris:

development and use of challenge strategies in the study of antidepression response. Prog Neuropsychopharmacol Biol Psych 1983; 7:273-286.

1. Stevenson JG, Eng SS, Munzenberger P. The use of nonsteroidal anti-inflammatory agents in the

management of juvenile rheumatoid arthritis. Hosp Pharm 1983; 18:293-296.

Non-Peer Reviewed 20. Lose J, Dorsch MP, Stevenson JG. Cost containment through reduction in drug waste:

experience at a single center. Pharmacy Times 2013; March (suppl):1-4. 19. Engels M, Ciarkowski S, Wagenknecht L, Stevenson JG. A statewide pediatric safety

collaboration to standardize compounded oral liquids. Michigan Pharmacist. 2012; 50(1): 28-9. 18. Stevenson JG (contributor). Tribute to Gloria Niemeyer Francke: Remembrances from family,

friends, students, and colleagues. Am J Health-syst Pharm 2009;66:258-278 17. Stevenson JG, Mitchell JF. Alternatives to reduce the use of meperidine in hospital practice.

Pharmacy Practice News April 2007. 16. Phan H, Pasko DA, Mitchell JF, Shoemaker DS, Glenn DK, Stevenson JG. Beyond the human

eye: using the ValiMed system to validate high-risk intravenous medications. Pharmacy Purchasing and Products 2005; 2(6):31.

15. Cousins DD, Hermes-DeSantis ER, Stevenson JG. Expert Opinions in Pharmaceutical Care:

Impact of Combined Drug Delivery Systems. Continuing Education Monograph Sponsored by the


Annenberg Center for Health Sciences at Eisenhower and Akita Consulting. July 2005. 14. Stevenson JG. Economic modeling and formulary management in erythropoietic therapy.

Formulary 2004: Suppl (May 2004). 13. Stevenson JG. Managing up: a key to effective leadership. Am J Health-Syst Pharm

2001;58(Suppl 1):S4-6. 12. Stevenson JG. Is the lottery a good way to distribute scarce drugs? (opinion). Hosp Pharm Report

1995; 9, (October):48.

11. Stevenson JG. New performance-focused JCAHO standards. Pharmacy Times 1994 (Suppl-September):7-14.

10. Stevenson JG. Therapeutic Management of Hypertension. Pharmat Continuing Education Program, Stockton CA, 1993.

9. Stevenson JG. Assess the effectiveness of drug control in the operating room. West Virginia Pharmacist 1991; 15.

8. Covington TR, Mallow LP, Henderson RP, Stevenson JG. Degenerative joint disease. The Consultant Pharmacist 1987; 2:404-412.

7. Petros WP, Stevenson JG. Case study: Crohn's disease. The West Virginia Pharmacist 1983; 7: -13.

6. Watkins R, Williams E, Stevenson JG. Update on new contraceptives. Pharm Practice 1983; 18:67.

5. Stevenson JG. Therapeutic management of hypertension. Pharmat Continuing Education Pilot Project, Pharmat, Inc, Stockton CA, 1983.

4. Stevenson JG, Covington TR. Commentary-EDTA in chelation therapy. Facts and Comparisons Drug Newsletter 1982: 1:63.

3. Stevenson JG, Covington TR. Chelation therapy of atherosclerosis (letter). Ann Intern Med 1982; 97:789-790.

2. Stevenson JG. Chelation therapy with disodium EDTA. Pharm Practice 1982; 17:87.

1. Vivian AS, Stevenson JG. Metronidazole: Cause as well as cure for colitis (letter). Am J Hosp Pharm 1981; 38:1442.

Books/Book Chapters/CD Compilation

16. Stevenson JG, Choe HM. Ambulatory care: Unprecedented opportunities to expand the contributions of pharmacists. In: Zellmer WA, ed. Pharmacy Forecast 2014-2018. Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems. Bethesda, MD: American Society of Health-System Pharmacists Research and Education Foundation 2013: 25-28.

15. Rice M, Adams J, Stevenson, JG. Cancer therapy preparation and administration basics, In:

Pham T, Holle LM,eds. Cancer Therapy Prescribing and Administration Basics. 1st ed.. Burlington, MA; Jones & Bartlett Learning 2013.


14. Mark SM, Saenz R, Clark JS, Stevenson JG. Leadership essentials for pharmacists, In:

Chisholm-Burns MA, Vaillancourt AM, Shepherd M (eds.), Pharmacy Management, Leadership, Marketing, and Finance. 2nd Edition. Burlington, MA. Jones and Bartlett Learning; 2012:23-36.

13. Stevenson JG. Use of computers and technology to enhance the safety of the medication use

process, In: Hussein, Ali Al Sayed (ed.), Pharmacy Practice. 1st Edition. Dubai, United Arab

Emirates. Dubai Health Authority, 2011:103-116. 12. Stevenson JG, McCreadie SR, Chaffee B. Informatics, In: Holford D, Brown T (eds),

Institutional Pharmacy Practice, 1st Edition. Bethesda, MD. American Society of Health-System

Pharmacists; 2010. 11. Callahan B, Blane CE, Stevenson JG. Improvement initiative. use of contrast media in the

radiology department. Case Study In: Mansur JM, ed. A Guide to the Joint Commission’s Medication Management Standards. Oakbrook Terrace, IL: Joint Commission Resources; 2009.

10. Stevenson JG, Schuman A.. Budget variance analysis and controlling operational results. In:

Wilson AL, ed. Financial Management for Health System Pharmacists. Bethesda, MD. American Society of Health-System Pharmacists; 2008.

9. Stevenson JG (ed). Innovations in medication safety. A compilation of medication safety articles from the Journal of Quality and Patient Safety, Oakbrook Terrace, IL, Joint Commission Resources; 2006.

8. Stevenson JG, McCreadie SR, Chaffee B. Informatics, In: Brown T (ed), Handbook of

Institutional Pharmacy Practics, 4th Edition. Bethesda, MD: American Society of Health-System Pharmacists; 2006:353-363.

7. Stevenson JG, Mitchell JF. Reducing the Use of Non-Approved Abbreviations. Case Study In: A Guide to JCAHO’s Medication Management Standards. Oakbrook Terrace, IL: Joint Commission Resources; 2004:142-146.

6. Stevenson JG, Mitchell JF. Controlling High Alert Medications. Case Study In: A Guide to

JCAHO’s Medication Management Standards. Oakbrook Terrace, IL: Joint Commission Resources; 2004:146-149.

5. Ellis JJ, Stevenson JG. Decision Analysis: A Case Study. In Pharmacoeconomics and Outcomes: Applications for Patient Care, Second Edition. Edited by Dennis Grauer, Jeff Lee, Tanner Odom, Jane Osterhaus, Lisa Sanchez, and Dan Touchette, American College of Clinical Pharmacy, Kansas City, November 2003.

4. Touchette DR, Mamdani MM, Massanari RM, Stevenson JG. Managing Uncertainty in Decision Analysis With Sensitivity Analyses. In: Slaughter RL, Edwards DJ (eds), Evaluating Drug Literature: A Statistical Approach. New York: McGraw Hill; 2001:269-293.

3. Touchette DR, Stevenson JG. Evaluating Pharmacoeconomic Literature. In: Slaughter RL,

Edwards DJ (eds), Evaluating Drug Literature: A Statistical Approach. New York: McGraw Hill; 249-268.

2. Review Board, Smith DL, ed., Understanding Prescription Drugs, New York: Simon and Schuster; 1986.


1. Technical Consultant, Smith DL, ed., Understanding Prescription Drugs, 2nd edition, New York: Simon and Schuster; 1987.

PRESENTATIONS

Informal and Innovative Leadership. Invited Keynote Lecture, Initiation Ceremony of the Delta Kappa chapter of the Phi Lambda Sigma National Pharmacy Leadership Society, University of Michigan College of Pharmacy, Ann Arbor, MI, March 26, 2014. A State-wide Initiative to Standardize the Compounding of Oral Liquids in Pediatrics. Platform presentation at the 2014 Michigan Pharmacists Association Annual Convention & Exposition, Detroit, MI, March 1, 2014. Preparing for the Introduction of Biosimilars: What Pharmacists and Pharmacy and Therapeutics Committees Need to Know. Invited presentation as part of a program on Biosimilars: An Update on Scientific, Legislative, and Safety Issues. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2013. Change in Pharmacy Practice: Does it Just Happen or Can It Be Planned? Lessons from the “Mirror to Hospital Pharmacy”. Invited presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2013. Mentoring the Next Generation of Health-System Pharmacy Leaders. Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2013. Barcode verification by certified pharmacy technicians as an alternative to pharmacists’ visual checks during dispensing. Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2013. Variability in compounding of oral liquids for pediatric patients: A patient safety concern. Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2013. Developing a Comprehensive Strategy to Improve Medication Safety. Invited presentation at New Challenges in Pharmacy 2013 Conference sponsored by American Society of Health-System Pharmacists. Riyadh, Saudi Arabia November 11, 2013 Jeddah, Saudi Arabia November 12, 2013 Formulary Considerations for Biosimilars. Invited presentation at New Challenges in Pharmacy 2013 Conference sponsored by American Society of Health-System Pharmacists. Riyadh, Saudi Arabia November 11, 2013 Jeddah, Saudi Arabia November 12, 2013 Ask the C-Suite: Communicating with Hospital Leadership. Invited Webinar Presentations on PharmacyAdvisor.com. October 2 and October 3, 2013. Biosimilar Formulary Considerations. Invited presentation at the Hematology Oncology Pharmacists Association (HOPA) Oncology Pharmacy Practice Management Program, Chicago, IL, September 2013.


HIPAA – The Health Insurance Portability and Accountability Act in the USA. Invited presentation as part of a session on “Healthcare Data – Safeguarding Confidentiality” at the 73rd International Congress of the International Pharmaceutical Federation (FIP), Dublin, Ireland, September 2013. Strategic Thinking and Planning for Success. Invited presention to the graduate students and administrative pharmacy residents, the Ohio State University Medical Center and College of Pharmacy, Columbus, OH, April 17, 2013. Preparing your Practice for Biosimilars. Invited presentation to the Idaho Society of Health-System Pharmacists, Boise, ID, April 2013. Strategic Thinking in Pharmacy Clinical Affairs. Invited presentation to the faculty of the University of Colorado School of Pharmacy as part of a strategic planning retreat. Golden, CO, January 8, 2013. Griffith N, Stevenson JG, McBride A, Tong C, Green L,. Formulary Selection Criteria for Biosimilars : Considerations for Health-System Pharmacists. Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. Berklich C, Kelley LR, Stevenson JG. Quality Improvement Pilot Based on Pharmacy Technician Actions for Access Problem Prevention (QUIPPTAPP). Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. ABC’s of ACOs. Invited presentation as part of the 2012 Pharmacy Leadership Forum, Pharmacy and the New Health Care Model: Roles and Responsibilities for Pharmacists. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. Introducing Biosimilars to Health Systems: The Pharmacist’s and P&T Committee’s Leadership Roles. Invited presentation as part of a program on Preparing for Biosimilars: Scientific, Regulatory, and Practice Management Issues for Pharmacists. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. Replaced by Technology: Could the EMR Materially Reduce the Role of the Pharmacist?. Participated as part of an invited panel discussion at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2012. Emergency - Not Enough Medicines: Best Case Solutions in Dealing with Drug Shortages - Hospital Pharmacy Perspective. Invited presentation and panel discussion at the Centennial World Congress, International Pharmaceutical Federation, Amsterdam, The Netherlands, October 5, 2012. Implementation of Team-Based Learning in a Therapeutics Course Sequence. Invited presentation and panel discussion at the Japanese International Symposium for Enhancement of the Pharmaco-Practical Education System (for Hospital Pharmacy and Community Pharmacy). Kyushu University Medical Center, Fukuoka, Japan, September 2, 2012. Leadership Lessons for Professional Success. Invited Commencement Speaker, Rush University Medical Center Pharmacy Residency Program, Chicago, IL, June 25, 2012. Residency Training as a Core to the Future. Invited presentation at the Seventh Annual Michigan Society of Health-System Pharmacists Residency Conference, Lansing, MI, June 4, 2012. Informal and Innovative Leadership. Invited Keynote Lecture, Initiation Ceremony of the Gamma Chi chapter of the Phi Lambda Sigma National Pharmacy Leadership Society, Wayne State University College of Pharmacy, Detroit, MI, April 6, 2012.


Academic Considerations with the Pharmacy Practice Model. Invited presentation at the Pharmacy Practice Model Initiative: Defining the Future of Pharmacy Practice, Cleveland Clinic, Cleveland, OH, July 22, 2011. Justification of Clinical Pharmacy Services. Invited presentation at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), Dubai, United Arab Emirates, March 2011. Antimicrobial Stewardship Programs Workshop: Strategies, Justification, and Measurement of Impact. Invited presentation at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), Dubai, United Arab Emirates, March 2011. Considerations in Selecting Inpatient Pharmacy Automation. Presented at the 16th Annual Congress of the European Association of Hospital Pharmacists (EAHP), Vienna, Austria, March 2011. Assessment of Rates of Adherence and Drug Interactions in Patients With Oral Cancer Therapy. Poster

presentation at the Hematology Oncology Pharmacists Association (HOPA) 7th Annual Conference, Salt Lake

City, UT, March 2011. Negotiating Job Offers. Presented to the Southeastern Michigan Residency Conference, Ann Arbor, MI, January 7, 2011. Evaluation of a Specialty Pharmacy Program in Solid Organ Transplantation. Poster presentation at the University Health-system Consortium (UHC) Pharmacy Council Meeting, Anaheim, CA, December 2010. Methods to Establish Criteria for Potential Selective Prospective Medication Order Review. Poster presentation at the University Health-system Consortium (UHC) Pharmacy Council Meeting, Anaheim, CA, December 2010. Intravenous Drug Delivery Systems in the US. Presented at KDA Hospital, Mumbai, India, and the All India Institute for Medical Sciences, New Delhi, India, November, 2010. Overview of the Incident Command System. Invited presentation at the Annual Meeting of the Michigan Society of Health-system Pharmacists, Grand Rapids, MI, November 5, 2010. Overcoming Inertia: Achieving More Rapid Transformation of Pharmacy Practice. John W. Webb Award Lecture presented as a visiting professor at Northeastern University, Bouve’ College of Pharmacy, Boston, MA, October 25, 2010. Overcoming Inertia: Achieving More Rapid Transformation of Pharmacy Practice. John W. Webb Award Lecture presented at the ASHP Leadership Conference, Chicago, IL, October 18, 2010.

Impact of a Pharmacist-Managed Chemotherapy-Induced Anemia Clinic. Poster presentation at the 70th International Congress of the International Pharmaceutical Federation (FIP), Lisbon, Portugal, September 2010. Practice Implications of Biosimilars, Invited Presentation as Part of Symposium on Biosimilars and Follow-on Biologics, 70th International Congress of the International Pharmaceutical Federation (FIP), Lisbon, Portugal, September 2010. Impact of a Pharmacist-Managed Chemotherapy-Induced Anemia Clinic. Poster presentation at the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, New Orleans, LA, March 2010.


Antimicrobial Stewardship Programs: Strategies, Justification, and Measurement of Impact. Invited presentation as part of an international exchange program sponsored by the Japanese Society of Hospital Pharmacists and the Japanese Ministry of Health, Labour, and Welfare on the theme "Studies of the Methods of Pharmaceutical Activity in Japanese Hospitals and Their Evaluation".

Annual Meeting Fukuoka Prefecture Society of Hospital Pharmacists, Fukuoka, Japan, February 21, 2010 Kagoshima University Hospital Department of Pharmacy Services, Kagoshima, Japan, February 26, 2010 Kanagawa Prefecture Society of Hospital Pharmacists, Yokohama, Japan, March 2, 2010

Expanding Clinical Pharmacy Services: Strategies, Justification, and Measurement of Impact. Invited presentation as part of an international exchange program sponsored by the Japanese Society of Hospital Pharmacists and the Japanese Ministry of Health, Labour, and Welfare on the theme "Studies of the Methods of Pharmaceutical Activity in Japanese Hospitals and Their Evaluation".

Kyushu University Hospital Department of Pharmacy Services, Fukuoka, Japan, February 22, 2010 Kagoshima Prefecture Society of Hospital Pharmacists, Kagoshima, Japan, February 24, 2010 Japanese Society of Hospital Pharmacists, Tokyo, Japan, March 5, 2010

Effect of the Implementation of Smart Patient Controlled Analgesia (PCA) Pumps on PCA Administration Safety. Poster presentation at the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2009

Impact of a Pharmacist-Managed Chemotherapy-Induced Anemia Clinic. Poster presentation at the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2009.

Needs and Opportunities in Informatics and Decision Support Tools in Oncology Pharmacy Practice. Presented at the National Comprehensive Cancer Network (NCCN) Pharmacy Directors Meeting, Washington, DC, October 2009.

Security of Supply for Emergency Patient Scenarios. Invited platform presentation as part of a program entitled Being Ready: Preparation to Ensure Positive Patient Outcomes in a Mass Casualty Situation. International Pharmaceutical Federation Annual Congress, Istanbul, Turkey, September 2009

The Effect of the Implementation of Smart PCA Pumps on PCA Administration Safety. Poster presentation at the International Pharmaceutical Federation (FIP) Congress, Istanbul, Turkey, September 2009. Antimicrobial Stewardship Programs: Applying Theory to Practice. Presented to faculty and students at Doshisha Women’s College of Pharmacy, Kyoto, Japan, May 2009. Achieving the Vision: ASHP 2015 Initiative. Presented to the Indiana Pharmacy Alliance, Fort Wayne, IN, April 2009 Impact of Pharmacist Review of Patients With Presumed Heparin-Induced Thrombocytopenia

and the Use of Direct Thrombin Inhibitors and Fondaparinux. Poster presentation at the 43rd Annual ASHP Midyear Clinical Meeting, Orlando, FL, December 2008. Evaluating Growth Factor Use and Management in Contemporary Practice. Presented to the Northern Michigan Society of Health-system Pharmacists, Gaylord, MI, October 16, 2008.


Therapeutic Pillars of Cancer Supportive Care: Growth Factors, Anti-emetics, and Anticoagulant Therapy. Presented to the South Florida Society of Health-system Pharmacists, Ft. Lauderdale, FL, October 8, 2008. Antifungal Drug Costs and Utilization Following Implementation of a Posaconazole Prophylaxis Protocol in Patients with Acute Myelogenous Leukemia. Poster presentation at the American College of Clinical Pharmacy Annual Meeting, Louisville, KY, October 2008. Evaluating Accuracy of Diagnosing Heparin-Induced Thrombocytopenia in a University Hospital. Poster presentation at the Society of Critical Care Medicine Annual Congress, Honolulu, HI, February 2008. Enhancing Drug Cost Reports with Customized Therapeutic Classifications. Poster presentation at the

42nd Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2007.

Assessment of the Resources Consumed by Health-system Pharmacy Departments When Performing a

Formulary Conversion. Poster presentation at the 42nd Annual ASHP Midyear Clinical Meeting, Las

Vegas, NV, December 2007

Automated Technologies to Enhance the Medication Use Process. Invited presentation at the 17th Peruvian Scientific Congress of Pharmacy and Biochemistry Students, Los Andes Peruvian University, Huancayo, Peru, November 2007. Justification of an ID Physician and Pharmacy Antimicrobial Stewardship Team Approach. Invited

presentation at the 17th Peruvian Scientific Congress of Pharmacy and Biochemistry Students, Los Andes

Peruvian University, Huancayo, Peru, November 2007. Collaboration Between Departments of Pharmacy Services and Colleges of Pharmacy. Invited presentation at the First International Conference on the Future of Pharmacy Education and Practice in the Arab World, Damascus, Syria, November 2007. Post Graduate Training Programs and the Clinical Pharmacists Role. Invited workshop presentation at the First International Conference on the Future of Pharmacy Education and Practice in the Arab World, Damascus, Syria, November 2007. Pharmacists, Pharmaceutical Manufacturers, and Conflicts of Interest: University Health Consortium Membership Survey. Poster presentation at the 2007 Annual Meeting of the American College of Clinical Pharmacy, Denver, CO, October 2007. The Impact of Patient Financial Incentives on Participation and outcomes in a Statin Pill-Splitting Program. Presented as a poster at the 2007 International Pharmaceutical Federation Congress, Beijing, China, September 2007.

A Blueprint for Growth Factor Therapy: Integrating Recent Evidence. A University Pharmacotherapy Associates (UPA) Continuing Education Program:

Salem Community Hospital Pharmacy, Salem, OH May 10, 2007 Wadsworth Hospital Pharmacy Department, Wadsworth, OH May 10, 2007 Detroit Medical Center Pharmacy Department June 20, 2007

Creating Luck in Your Pharmacy Career. Commencement Address to the Pharmacy Graduating Class of 2007, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, May 2, 2007.


Evolving Issues: Interface with the Pharmaceutical Industry. Presented at the Pharmacy Council Meeting, University Health-system Consortium (UHC), Anaheim, CA, December 2, 2006.

Enhancing Pharmacy Services to Improve Quality and Safety in Oncology. Presented to faculty and pharmacists at Kyushu University Hospital and other Kyushu hospital pharmacy departments, Fukuoka, Japan, October 6, 2006.

Use of Fluorometric Analysis to Improve the Safety of Compounding of High Alert Parenteral Medications. Presented as a poster at the 2006 International Pharmaceutical Federation Congress, Salvador, Brazil, August, 2006.

Contemporary Challenges in Health System Pharmacy Practice. Presented at the First Annual MSHP Residency Conference, Michigan Society of Health-system Pharmacists, Lansing, MI, May 19, 2006.

How to Justify Clinical Pharmacy ID Services: A Workshop. Presented at the Ninth Annual Making A Difference in Infectious Diseases Conference (MAD-ID), Orlando, FL, May 14, 2006.

Plenary Session: Antibiotic Stewardship: What Can Be Accomplished? Justification of an ID Physician and Pharmacist Approach. Presented at the Ninth Annual Making A Difference in Infectious Diseases Conference (MAD-ID), Orlando, FL, May 12, 2006

University of Michigan Vendor Policy and Experience. Presented at the Pharmaceutical Marketing Forum, Hospital of the University of Pennsylvania, Philadelphia, PA, May 2, 2006.

Enhancing Erythropoietic Therapy: Charting Recent Advances. A University Pharmacotherapy Associates (UPA) Continuing Education Program:

Boca Raton Memorial Hospital, Boca Raton, FL, May 3, 2006 Bethesda Memorial Hospital, Boynton Beach, FL, May 4, 2006 St. Joseph Hospital Macomb, ClintonTownship, MI June 5, 2006 Resurrection Health System, Chicago, IL, October 18, 2006 Midland County Pharmacists Association, Freeland, MI, October 25, 2006

Collins CD, Stuntebeck ER, DePestel DD, McCloskey BJ, Stevenson JG. Evaluation of Treatment and Toxicity Associated Costs of Liposomal Amphotericin B versus Voriconezole for Empiric Treatment of Febrile Neutropenia: A Decision Analytical Model. Presented at the Spring Practice and Research Forum, American College of Clinical Pharmacy (ACCP), April 9-12, 2006, Monterey, California. Use of Fluorometry to Enhance Safety in the Compounding of High-Risk Parenteral Medications. Presented at the Michigan Pharmacists Association Annual Convention & Exposition, Dearborn, MI, February 17, 2006. The Use of Spectroscopy to Improve Medication Safety. Presented as a component of the Informatics

Bytes: Pearls of Information session, 40th Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2005.

Stability of Misoprostol in Vaginal Suppositories. Poster presentation at the 40th ASHP Midyear Clinical

Meeting, Las Vegas, NV, December 2005. Improving Medication Safety: Use of Spectral Medication Validation in High Risk Intravenous Medication

Compounding in a Pediatric Hospital Pharmacy. Poster presentation at the 40th ASHP Midyear Clinical

Meeting, Las Vegas, NV, December 2005.


Assessment of Pharmacist Understanding and Performance Related to Drug Use Policies and Safety

Practices. Poster presentation at the 40th ASHP Midyear Clinical Meeting, Las Vegas, NV, December

2005. The Future of Medication–Use Automation: Strategies to Optimize Your Investment. Maximizing Your

Current Investment. Invited panel presentation as part of an Exhibitor Theater at the 40th ASHP Midyear

Clinical Meeting, Las Vegas, NV, December 2005. Fluorometry Testing for High Risk Parenterals. Invited presentation to the University Health-System Consortium Pharmacy Council Meeting, Las Vegas, NV, December 2005. Review and Development of Outpatient Oncology Clinical Pharmacy Services. Poster presentation at the University Health-System Consortium Pharmacy Council Meeting, Las Vegas, NV, December 2005. Impact of and Compliance With a Protocol for the Use of Recombinant Factor VIIa. Poster presentation at the University Health-System Consortium Pharmacy Council Meeting, Las Vegas, NV, December 2005. Sensitivity/Specificity Evaluation of Fluorometry to Enhance Safety in the Compounding of High-Risk Parenteral Medications. Poster presentation at the University Health-System Consortium Pharmacy Council Meeting, Las Vegas, NV, December 2005. USP Chapter 797 Compliance: Quality in Action. Invited presentation at the Annual Meeting of the Michigan Society of Health-system Pharmacists, Lansing, MI, November 2005. Erythropoietic Growth Factor Therapeutic Interchange Program in Hospitalized Hemodialysis Patients. Invited presentation for the Nephrology PRN at the American College of Clinical Pharmacy Annual Meeting, San Francisco, CA, October 2005. The Combined Impact of Prevention Category and Co-Payment Tier on Statin Non-Adherence and

Discontinuation. Presented at the 65th International Congress of the International Pharmaceutical Federation (FIP), Cairo, Egypt, September 2005.

How to Justify Clinical Pharmacy ID Services: A Workshop. Presented at the Eighth Annual International Conference of Infectious Diseases Pharmacotherapy, Carefree, AZ, May 15, 2005.

Management of Erythropoietic Therapy: Economic Considerations and Therapeutic Interchange. Presented at the Annual Meeting, West Virginia Society of Health-System Pharmacists, Morgantown, WV, April 30, 2005.

Cost Analysis of a Febrile Neutropenia Algorithm with Respect to Empical Antifungal Therapy in Adult

Hematology/Oncology Patients. Poster Presentation at the ISPOR 10th Annual International Meeting,

Washington DC, May 2005. The Impact of Specialty Care on the Utilization of New Drugs: The Case of Cox-2 Selective Inhibitors.

Poster Presentation at the ISPOR 10th Annual International Meeting, Washington, DC, May 2005.

Assessment of Pharmacist Understanding and Performance Related to Drug Use Policies and Safety

Practices. Poster Presentation at the 39th Annual ASHP Midyear Clinical Meeting, Orlando, FL, December 2004 Clinical and financial outcomes of a therapeutic interchange program for erthropoietic growth factors in

adult patients with kidney failure on hemodialysis. Poster Presentation at the 39th Annual ASHP Midyear Clinical Meeting, Orlando, FL, December 2004


Development of a Specialty Residency in Pharmacy Informatics and Technology. Management Case Study.

Presented at the 39th Annual ASHP Midyear Clinical Meeting, Orlando, FL, December 2004

Real World Financial Considerations and Therapeutic Interchange with Erythropoietic Growth Factors. Part of a University Pharmacotherapy Associates symposium entitled “Late Breaking Evidence: Inpatient /

Outpatient Growth Factors - Conversions, Costs, and Critical Use. Exhibitor’s Theater at the 39th Annual ASHP Midyear Clinical Meeting, Orlando, FL, December 7, 2004,

Evidence and Value Crossroads: Clarifying Contemporary Erythropoietic Growth Factor Issues. Co-Chaired National Scientific Education Panel and presented on “Real World Financial Considerations”, University Pharmacotherapy Associates, San Francisco, CA, September 2004

Management of Erythropoietic Therapy: Economic Considerations and Therapeutic Interchange. Presented

at the 38th Annual Meeting, Florida Society of Health-System Pharmacists, Orlando, FL, August 7, 2004.

Management of Erythropoietic Therapy: Economic Considerations and Therapeutic Interchange. Presented to the Department of Pharmacy Services:

Northwestern University Hospital, Chicago, IL, April 14, 2004

University of Chicago Hospitals, Chicago, IL, April 14, 2004

Rush Presbyterian Hospital, Chicago, IL, April 14, 2004

University of Nebraska, Omaha, NE, April 22, 2004

MD Anderson Cancer Center, Houston, TX, December 15, 2004

Potential Cost Savings of Pre-Filling Individual Doses of Three High Cost Parenteral Medications. Poster

presentation at the 38th Annual ASHP Midyear Clinical Meeting, New Orleans, LA, December 2003.

Economic Modeling and Formulary Management in Erythropoietic Therapy. Invited poster presentation in “Contrasting Perspectives on Erythropoietic Growth Factor Guidelines in Anemia”, University Pharmacotherapy Associates, New Orleans, LA, December 8, 2003.

Relationships Between Pharmaceutical Industry and Practitioners: A New “Drug Interaction” is Needed. Presented to the Washtenaw County Medical Society, Ann Arbor, MI, September 30, 2003.

Using Economic Modeling to Make Formulary Decisions: A Case Study in Anemia Management. Presented to the New York Council of Health System Pharmacists Midyear Clinical Meeting and Exhibits

Tarrytown, NY, September 17, 2003

Buffalo, NY, October 14, 2003

Altering Prescribing Patterns of Meperidine to Improve Patient Safety. Poster Presentation at the 63rd Annual Congress of the International Pharmacy Federation (FIP), Sydney, Australia, September 4-9, 2003.

Managed Care Tiered Co-Pay Systems. Reactor panel participant. Pfizer Medical and Research Specialists/Outcomes Research, Ann Arbor, MI, June 2003.

Altering the Prescribing Patterns of Meperidine: A Patient Safety Initiative. Poster Presentation at the 2nd Annual Patient Safety Conference, Patient Safety Leadership Through Innovation and Evolution, Michigan Health and Safety Coalition, Dearborn, MI, April 30-May 1, 2003.

Prescription Drug Expenditures in the US. Invited 11th Annual Frances P. Rhoades Memorial Lecture,

Presented to the Wayne County Medical Society, Detroit, MI, March 21, 2003.

Pharmacoeconomic Considerations in Anemia Management: A Case Study. Presented to Amgen Hospital Pharmacy Advisory Board, Miami, FL, February 2003.


Darbepoetin/Epoetin Economic Analysis: A Case Study. Presented to the Department of Pharmacy Services, St. John Health System, Grosse Pointe, MI, January 2003.

Economic Impact Modeling of the Addition of Darbepoetin Alfa to a Health-System Formulary. Management

Case Study Presented at the 37th Annual ASHP Midyear Clinical Meeting, Atlanta, GA, December 2002.

Implementation of a Cytotoxic Chemotherapy Policy. Management Case Study Presented at the 37th Annual

ASHP Midyear Clinical Meeting, Atlanta, GA, December 2002.

Economic Evaluation of Darbepoetin and Epoetin Alfa. Presented to the Department of Pharmacy Services Staff, Oakwood Health System, Dearborn, MI, October 16, 2002.

Sub-optimal Statin Compliance in Primary and Secondary Prevention Populations: Should We Target

Patients With the Most to Gain? Platform presentation at the 7th Annual International Meeting,

International Society for Pharmacoeconomics and Outcomes Research, Crystal City, VA, May 21, 2002.

Interpreting and Applying Pharmacoeconomic Analyses Within a Hospital Setting. Presented to the Student Chapter of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), University of Michigan College of Pharmacy, November 2001.

Interpreting and Applying Pharmacoeconomic Analyses Within a Hospital Setting. Invited presentation by the Economics and Outcomes Research PRN Group as part of a program on Applying Sensitivity Analyses to the Drug Therapy Decision, American College of Clinical Pharmacy Annual Meeting, Tampa, FL, October 2001.

Voucher Systems: An Alternative to Sample Medications. Presented at the Michigan Society of Health-system Pharmacists Annual Meeting, Novi, MI, October 2001.

Analyzing the Cost Implications of Drotrecogin Alfa (Activated) at Your Institution. Presented as part of the symposium “The Rational Use of Drotrcogin Alfa in Severe Sepsis: A Workshop for Health System Pharmacists”, Dearborn, MI, August 2001.

Clinician’s Orders Online: New Possibilities; New Challenges. Discussion Panel Participant, University of Michigan Program in Society and Medicine, Forum on Health Policy, Ann Arbor, MI, May 2001.

Managing Up: A Key to Effective Leadership. Presented at the Michigan Pharmacists Association 2001 Annual Convention and Exposition, Dearborn, MI, February 2001.

Managing Up: A Key to Effective Leadership. Presented at a symposium entitled “Principles of Managing Up: Operational and Financial. Sponsored by Aventis Behring and Premier, Inc. Presented at the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2000. Correlation and Clinical Assessment of a Portable PT/INR Monitor in a Cardiology Ambulatory Clinic. Presented at the 2000 Annual Meeting, ACCP, Los Angeles, CA, November 2000.

Practice Management Issues in Critical Care Pharmacy. Presented at the 2nd Annual Michigan-Ohio Critical

Care Pharmacy Symposium, Toledo, OH, April 2000.

Pharmacoeconomic Analysis of Processing Non-formulary Drug Requests: Exploring a Tiered Approach.

Presented at the 34th ASHP Midyear Clinical Meeting, Orlando, FL, December 1999.

Pharmacy/Pharmaceutical Industry Issues. Presented at the Pharmaceutical Representatives Invitational, Michigan Society of Health-System Pharmacists Annual Meeting, Lansing, MI, October 1999.


Cost-Effectiveness of Increasing Warfarin Usage for Stroke Prophylaxis in Patients with Atrial Fibrillation. Presented at the 4th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City, VA, May 25, 1999.

A Comprehensive Program to Manage Anticoagulation Therapy in Underserved Urban Communities: Establishing a Prothrombin Time Monitoring System and Protocol. Presented at the 5th National Conference on Anticoagulant Therapy, Vancouver, British Columbia, Canada, May 1999.

Justification of Comprehensive Anticoagulation Services. Presented at “Contemporary Approaches to Anticoagulation Disorders”, a multidisciplinary conference sponsored by the Improving Anticoagulation in Detroit Task Force, Wayne State University School of Medicine and the Detroit Medical Center, Dearborn, MI, March 1999

A Cost Analysis of a Community-Acquired Pneumonia Critical Pathway. Presented at the 33rd ASHP Midyear Clinical Meeting, Las Vegas, NV, December 1998.

Use of Sensitivity Analysis Techniques in Evaluating Decisions. Presented at the Tri-University Pharmacy Fellowship Conference, Chicago, IL, May 1998.

Developing a Markov Model for Non-Small Cell Lung Cancer Treatment. Presented at the Tri-University Pharmacy Fellowship Conference, Chicago, IL, May 1998.

Pharmacy Practice in the Year 2000. Presented at the Second Annual Detroit Receiving Hospital and University Hospital Symposium on Innovative Practice Roles for Pharmacists, Dearborn, MI, February 1998.

The Save 100 Initiatives. Presented at the 1998 Michigan Pharmacists Association Annual Convention and Exposition, Dearborn, MI, February 1998.

Sensitivity Analysis: An Explicit Tool for Analyzing Difficult Problems. Presented to the Center for Healthcare Effectiveness Research, Wayne State University, Detroit, MI, November 1997.

Clinical and Economic Analysis of an Inpatient Anticoagulation Service. Presented at the Inter-University Fellowship Forum, Minneapolis, MN, April 1997.

Will today’s pharmaceutical data be enough for tomorrow’s formulary decisions?. Presented at a meeting of the Detroit Pharmaceutical Representatives Association, Southfield, MI, April 1997.

Introduction to the Save 100 Initiatives. Presented to chief executive officers, medical chiefs of staff, and directors of pharmacy in southeastern Michigan hospitals.

March 6, 1997 North Oakland Medical Center March 11, 1997 St. John Hospital and Medical Center March 18, 1997 Oakwood Hospital March 27, 1997 The Detroit Medical Center

Development of a competency-based professional development ladder in a 2000 bed integrated health care system. Presented at the 31st ASHP Midyear Clinical Meeting, New Orleans, December 1996.

Impact of Medicaid Changes on Healthcare Systems. Presented to the Glaxo Wellcome Advisory Board, Ann Arbor MI, August 1996.

Use of Decision Analysis in Pharmacoeconomic Evaluation. Presented to the Faculty and Staff, University of Michigan School of Pharmacy and Medical Center, Ann Arbor, MI February 1996.


Thromboembolism Prophylaxis in Moderate Risk Patients Undergoing Elective Abdominal Surgery: Decision and Cost-Effectiveness Analyses. Presented at the ACCP Winter Research Meeting, Monterey, CA, February 1996.

Principles of Pharmacoeconomics. Presented as part of a conference entitled "The Economics of Therapeutics in a Changing Health Care Environment". Sponsored by the Wayne State University School of Medicine and College of Pharmacy, Ypsilanti, MI, November 1995.

Evaluation of Pharmaceutical Marketing Practices: Pharmaceutical Representatives' Perspective. Presented at the Annual Meeting of the American College of Clinical Pharmacy, Washington, D.C., August, 1995.

Impact of Pharmaceutical Care and Comprehensive Education by Pharmacists on Outcomes of Patients with Asthma. Presented at the ASHP Annual Meeting, Philadelphia, PA, June 1995.

Assessing the Impact of Computerizing Pharmacists' Interventions. Presented at the ASHP Annual Meeting, Philadelphia, PA, June 1995.

Restructuring Pharmacy Operations: Outsourcing TPN Preparation. Presented at the ASHP Annual Meeting, Philadelphia, PA, June 1995.

Principles of Pharmacoeconomics and Outcomes Research. Presented to the Kent County Pharmacists Association, Grand Rapids, MI, May 1995.

Pharmacoeconomic Evaluation in the Managed Care Environment. Presented to the Pharmacy Staff, Henry Ford Health Systems/Metro Medical Group, Southfield, MI, December 1994.

Michigan Invitational Pharmaceutical Care Conference. Invited Facilitator for Workshops on Implementation of Pharmaceutical Care, Lansing, MI, March 1994.

Principles of Pharmacoeconomics. Presented to the Detroit Pharmaceutical Representatives Association, Detroit, MI, March 1994.

Implementing Pharmaceutical Care: The Detroit Receiving Hospital Experience. Presented to the Faculty and Staff, University of Colorado Health Sciences Center, Denver, CO, February 1994.

Computerized System to Improve the Documentation of Pharmacist's Clinical Interventions, Cost Avoidance and Workload Activities. Presented at the 28th Annual ASHP Midyear Clinical Meeting, Atlanta, GA, December 1993.

Calcium Channel Blocker Delivery Systems. Continuing Education Program Presented to Metropolitan Detroit Area Physicians, Detroit, MI, December 1993.

Calcium Channel Blocker Delivery Systems. Continuing Education Program Presented to Metropolitan Detroit Area Pharmacists, Detroit, MI, October 1993.

Implementing Pharmaceutical Care: Pharmacy's Imperative for the 90's. Presented to the Southeastern Michigan/Northern Ohio Resident's Conference, Detroit Receiving Hospital, October 1993.

Review of Pharmaceutical Calculations. Presented to the Department of Pharmacy Services, Detroit Receiving Hospital, October, 1993.

Implementing Pharmaceutical Care: Pharmacy's Imperative for the 90's. Presented to the Departments of Pharmacy Services, Detroit Medical Center, Detroit, MI, February 1993.


Clinical Trial Management by a Hospital Pharmacy-Based Clinical Research Division. Presented at the 27th Annual ASHP Midyear Clinical Meeting, Orlando, FL, December 1992

Compensation for Investigational Drug Services. Roundtable Discussion at the Annual Meeting of the American College of Clinical Pharmacy, Toronto, Canada, August 1992.

Clinical Trial Management by a Pharmacy-Based Clinical Research Division. Poster Presentation at the 16th Annual Meeting, Associates of Clinical Pharmacology, Miami Beach, FL, May 1992.

The Impact of New Biotechnology Agents on Hospital Pharmacy Practice. Presented to the Southeastern Michigan/Northern Ohio Residents Meeting, Detroit, MI, January 1992

Formulary and Pharmacokinetic Considerations in the Management of Gram Negative Infections. Presented at the Annual West Virginia University Microbiology/Infection Control Seminar, Morgantown, WV, July 1991.

Development of a Pharmacy-Based Clinical Research Division in a University Teaching Hospital. Presented to the Faculty of the College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI, June 1991.

Development and Evaluation of Pictorial Teaching Materials for Functionally Illiterate Adult Type II Diabetic Patients. Presented at the 10th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Baltimore MD, April 1991.

Evaluation of Extemporaneously Compounded Antimicrobial Ophthalmic Solutions. Presented at the 10th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Baltimore MD, April 1991.

The Impact of New Biotechnology Agents on Hospital Pharmacy Practice. Presented to the Appalachian Valley Pharmacists Association, Martinsburg, WV, February 1991.

The Impact of New Biotechnology Agents on Pharmacy Practice. Presented at the Southern Appalachian Pharmacists Association, Pipestem, WV, October 1990.

The Impact of New Biotechnology Agents on Hospital Pharmacy Practice. Presented at the Annual Meeting of the West Virginia Society of Hospital Pharmacists, Charleston, WV, May 1990.

Implementation of a Patient-Education Program for Metered Dose Inhalers. Presented at the Eastern States Conference for Pharmacy Residents and Preceptors, Boston, MA, April 1990.

The Effect of the New Biotechnology Agents on Pharmacy Practice. Presented at the Annual Meeting of the Ohio-Marshall Counties Pharmacists Association, Wheeling, WV, March 1990.

Cost-Effectiveness of Converting from Intravenous Ranitidine to Oral Therapy. Presented at the 24th Annual ASHP Midyear Clinical Meeting, Atlanta, GA, December 1989.

Improving Preoperative Antimicrobial Administration Practices in a University Teaching Hospital. Presented at the 24th Annual ASHP Midyear Clinical Meeting, Atlanta, GA, December 1989.

Safe Handling of Cancer Chemotherapy. Presented at Oncology Grand Rounds, West Virginia University Hospitals, Morgantown, WV, June 1989.

Development of a Pharmacokinetic Dosing Service Utilizing all Professional Staff in a University Teaching Hospital. Presented at the Eastern States Conference for Pharmacy Residents and Preceptors, Cherry Hill, NJ, April 1989.


H2-Antagonist Therapeutic Equivalence Program at WVU Hospitals. Presented to the Pharmacy and Medical Staff, St. Joseph's Hospital, Parkersburg, WV, May 1989.

Therapeutic Drug Monitoring: Cost Savings Through Pharmacy Intervention. Presented at the 23rd Annual ASHP Midyear Clinical Meeting, Dallas TX, December 1988.

Comparison of the Safety and Efficacy of Cilazapril Versus Captopril in Patients With Essential Hypertension. Presented at the 23rd Annual ASHP Midyear Clinical Meeting, Dallas TX, December 1988.

Update on H2-Receptor Antagonist Therapy. Presented to the West Virginia Society of Hospital Pharmacists, Parkersburg WV, September 1988.

A Cardiopulmonary Resuscitation Training Program for Pharmacists. Presented at the Eastern States Conference for Pharmacy Residents and Preceptors, Baltimore MD, April 1988.

New Developments in the Management of Ulcer Disease. Presented at the Annual Meeting of the Ohio-Marshall Counties Pharmacists Association, Wheeling WV, March 1988.

Drug Information Provision: A Quality Assurance Program. Presented at the Eastern States Conference for Pharmacy Residents and Preceptors, Baltimore MD, April 1987.

3-in-1 Admixture System is More Cost-effective than Conventional TPN. Presented at the 11th Clinical Congress of the American Society for Parenteral and Enteral Nutrition, New Orleans LA, February 1987.

Treatment of Supraventricular Arrhythmias Using Continuous Intravenous Infusions of Verapamil. Presented at the 21st Annual ASHP Midyear Clinical Meeting, Las Vegas NV, December 1986.

A Comparative Evaluation of Four Ampicillin Admixture Systems. Presented at the 21st Annual ASHP Midyear Clinical Meeting, Las Vegas NV, December 1986.

Pharmacy Rounds: A Vehicle to Increase Patient-Oriented Practice. Platform Management Case Study presented at the 21st Annual ASHP Midyear Clinical Meeting, Las Vegas NV, December 1986.

The Benefits of a Clinical Pharmacokinetic Consult Service. Presented at the Clinical Laboratory Conference, West Virginia University Hospitals, Morgantown WV, October 1986.

Development of a Critical Care Manual for Pharmacists and Nurses. Presented at the Eastern States Conference for Pharmacy Residents and Preceptors, Philadelphia PA, May 1986.

Evolution From a Distributional to a Patient-Oriented Pharmacy Service. Platform Management Case Study presented at the 20th Annual ASHP Midyear Clinical Meeting, New Orleans LA, December 1985.

Use of dBase III in the Measurement and Application of Patient-Oriented Productivity Data. Presented at the 20th Annual ASHP Midyear Clinical Meeting, New Orleans LA, December 1985.

Pharmacy-Based, Computer-Assisted Concurrent Review of Parenteral Vancomycin Use in a University Hospital. Presented at the 20th Annual ASHP Midyear Clinical Meeting, New Orleans LA, December 1985.

Pharmacokinetics of Stimulants Used in the Treatment of Attention Deficit Disorders. Presented at the Clinical Child Psychiatry Grand Rounds, West Virginia University Hospitals, Morgantown WV, April 1985.


Contemporary Management of Hypertension: Case Studies and Clinical Correlates. Invited platform presentation. Presented at the Annual Meeting of the American Pharmaceutical Association, San Antonio TX, February 1985.

Sustained Lidocaine Levels Using Timed Bolus Administration in the Prehospital Setting. Presented at the 19th Annual ASHP Midyear Clinical Meeting, Dallas TX, December 1984.

Development and Evaluation of "Advanced Therapeutics" for nontraditional Pharm.D. Students. Proceedings of the Annual Meeting of the American Association of Colleges of Pharmacy, Baltimore MD, July 1984

Recent Advances in the Management of Hypertension: New Drugs, New Recommendations. Presented to the Southern West Virginia Pharmacists Association, Huntington WV, June 1984.

Considerations When Recommending OTCs for Geriatric Patients. Presented at a seminar sponsored by the Schering Corporation and West Virginia University, Morgantown WV, March 1984.

Medical Team Clerkship. Presented at the West Virginia University Pharmacy Preceptors Conference, Morgantown WV, November 1983.

New Cardiovascular Agents. Presented at the Annual Fall Seminar, West Virginia University School of Pharmacy, Morgantown WV, October 1983.

Recent Advances in the Treatment of Insomnia. Presented at the 22nd Annual Pharmacy Postgraduate Seminar, West Virginia University, Morgantown WV, April 1983.

Recent Advances in the Treatment of Insomnia and Inflammatory Disorders. Presented at the 1983 Interim Meeting, West Virginia Pharmacists Association, Charleston WV, March 1983.

Pupillometry and the Effect of Tranylcypromine on Muscarinic and Alpha-Adrenergic Receptor Sensitivity in Depressed Patients. Invited platform presentation, Psychopharmacy Practice Special Interest Group. ASHP Midyear Clinical Meeting, Los Angeles CA, December 1982.

Pupil pharmacology in Affective Disorders. Proceedings of the Annual Meeting, American Psychiatric Association, Toronto, May 1982.

Antibiotic-Induced Pseudomembranous Colitis. Presented at the Michigan Pharmacists Association Interim Meeting, Dearborn MI, February 1982.

Pupillometry and Receptor Sensitivity in Affective Disorders. Presented to the Medical Staff, Detroit Psychiatric Institute, May 1981.

Medical Management of Cancer Pain. Presented to the Pharmacy Staff, Harper-Grace Hospitals, Harper Hospital Division, Detroit MI, April 1981.

RESEARCH /GRANT SUPPORT

Aging in Place. University of Michigan “Global Challenges for a Third Century” grant program. Alan Dengiz-PI. Funding Period December 2013-November 2014. ($242,946). Role: Co-Investigator. Submitted September 2013. Effectiveness of physician pharmacist collaborative medication management in CKD. National Institutes of Health, Diabetes, Digestive, and Kidney Diseases Extramural Research, R34 (93.847). Submitted July 2013 ($699,750). Role: Co-Investigator.


Enabling Patient-Centered Care with Advanced Mobile Monitoring. University of Michigan “MCubed Initiative” grant program. Patricia Abbott- Project Owner. Funding Period July 2013-August 31, 2014. ($60,000). Role: Co-Investigator. UM as the Engine of a Global “Learning System” to Transform Health. University of Michigan “Global Challenges for a Third Century” grant program. Charles Friedman-PI. Funding Period May 2013-September 2014. ($293,553). Role: Member of Coordinating Committee and Technology Task Force. A State-wide Pediatric Safety Collaboration to Standardize Compounded Oral Liquids. FDA’s Novel Interventions and Collaborations to Improving the Safe Use of Medications Cooperative Agreement Program (U01) RFA-FD-11-024. Funding Period Sept 15, 2011-2014. ($150,000 over 3 years). Award #1U01FD004259-01 Funded September 2011. Role: Principle Investigator Assessing the Effect of a Handheld Decision Support Device for Reducing Medication Errors. US Department of Defense, U.S. Army Medical Research and Materiel Command's (USAMRMC) Broad Agency Announcement (BAA) 10-1 to provide solutions to medical problems of importance to the American war fighter at home and abroad. Award # W81XWH-10-1-0606 ($703,000, UM subcontract amount $148,758), Funded September 2010. Role: Co-PI. University of Michigan/Abbott Laboratories Outcomes Research Fellowship, Funded by Abbott Laboratories ($148,000 for 2009-2011). Role: Co-PI

InformMed Database Validation, Funded by InformMed, Inc. ($4663), September 2007. Role: PI

Support for Pharmacy Grand Rounds at the University of Michigan, Allergan Pharmaceuticals ($15,000). 2008. Role: PI

Residency Stipend Support, Amgen Foundation ($38,000- 2005; $38,000 – 2006, $38,000 – 2007, $40,000 - 2008). Role: PI

Value Based Benefits for UM Employees at Risk for CVD Events, Funded by the University of Michigan Office of the President, Healthy Communities Initiative, ($250,000 July 2006). Role: Co-investigator

Pharmacy Technician Training Program Capacity Enhancement. Funded by the Accelerated Health Career Training Initiative sponsored through the Michigan Department of Community Health and the Michigan Department of Labor & Economic Growth ($139,772), July 2005. Role: Co-PI.

Impact of pill-splitting on economic and pharmacologic outcomes. Funded by the University of Michigan Office of Staff Benefits ($48,579). 2005. Role: Co-investigator.

Fellowship in Pharmacoeconomics and Outcomes Research, Funded by Pfizer Inc, ($104,000 – renewal for 2003-2005). Role: PI Prescription Drug Utilization Improvement, Funded by the Ford Fund, ($45,000). 2004. Role: Co-Investigator. Fellowship in Pharmacoeconomics and Outcomes Research at the University of Michigan, Funded by Pfizer, Inc. ($104,000 for 2001-2003). Role: Co-PI.

University of Michigan College of Pharmacy Drug Monograph Development Project for vCure.com. Funded by vCure.com ($215,184). 2002. Role: PI.

A Pharmacoeconomic Evaluation of Alternative Therapies Used in Clinical Practice for Patients with HIV. Funded by Agouron Pharmaceuticals ($20,000). 1999. Role: Co-investigator.


Proposal for a Pharmacotherapeutic Management Service for the Physicians’ Group Clinic, Harper Hospital. Funded by Detroit Medical Center/Wayne State University ($65,640). Role: Co-Investigator.

Cost-Effectiveness Model of Amifostine in Non-Small Cell Lung Cancer. Funded by Alza Pharmaceuticals. ($5000). Role: Co-PI.

Proposal to Create a Clinical Pharmacist Role in the HIV/AIDS Program at the Detroit Medical Center. Funded by Merck & Co; Inc. ($30,000). Role: Co-PI.

The “Save 100 Initiative”: Cost-Effective Prescribing of Drugs. Funded by General Motors Corporation/Chrysler Corporation /Blue Cross-Blue Shield of Michigan ($768,000). Role: Co-Investigator.

Pharmacoeconomic Assessment of a Calcium Channel Blocker Conversion Program. Funded by Astra Merck ($16,200). Role: Co-PI.

Management of Peptic Ulcer Disease: A Pharmacoeconomic Assessment. Funded as part of a Integrated Advanced Information Management System (IAIMS) grant awarded to Wayne State University/Detroit Medical Center by the National Library of Medicine ($32,000). Role: Co-Investigator.

Proposal to create a Fellowship Program in Pharmacoeconomics and Outcomes Research. Funded by Bristol-Myers Squibb Company ($120,000). Role: PI.

A Double-Blind, Randomized, Comparative Trial of Intravenous Aztreonam Versus Intravenous Ciprofloxacin in Hospitalized Patients Followed by Open-Label Oral Therapy For the Treatment of Complicated Urinary Tract Infections and/or Pyelonephritis. Funded by Institute for Biological Research and Development ($30,000). Role: Co-Investigator.

Double-Blind, Placebo Controlled Study of the Effect of Ceftizoxime Sodium in the Management of Patients with Preterm, Premature Rupture of Membranes. Funded by BioPharm Laboratories ($64,000). Role: Co-Investigator.

Multiple-Dose, Open-Label Clinical Trial of the Safety and Efficacy of Enoxaparin Compared to Unfractionated Heparin for the Prevention of Post-Operative Venous Thromboembolism Following Total Knee Replacement. Funded by Rhone-Poulenc Rorer ($110,000).. Role: Co-Investigator.

A Multi-Investigator Comparative Study of Cefepime and Ceftazidime in the Treatment of Serious Bacterial Infections. Funded by Bristol Myers Laboratories ($48,000). Role: Co-Investigator.

Multicenter Placebo Controlled Study Evaluating the Safety and Comparing the Antihypertensive Effect of Cilazapril (Inhibace) in combination with Hydrochlorothiazide Versus Cilazapril or Hydrochlorothiazide. Funded by Roche Laboratories ($51,480). Role: Co-Investigator.

Multiple-Dose, Double-Blind Clinical Trial of the Safety and Efficacy of Enoxaparin Versus Aspirin for the Prevention of Post-Operative Deep Vein Thrombosis Following Hip Fracture Surgery. Funded by Rhone-Poulenc Pharmaceuticals ($119,000). Role: Co-Investigator

A Comparative Study of Cefepime/Metronidazole and Gentamicin/Clindamycin in the Management of Surgically-Treated Intra-Abdominal Sepsis. Funded by Bristol Myers Laboratories ($48,048). Role: Co-Investigator.

Cost Benefits of a Pharmacy-Based Program of Converting From Intravenous to Enteral Ranitidine Therapy. Funded by Glaxo Pharmaceuticals ($7,850). Role: PI


Multiple-Dose, Open Label Clinical Trial of the Safety and Efficacy of Enoxaparin Versus heparin for the Prevention of Post-Operative Deep Vein Thrombosis Following Total Hip Replacement Surgery. Funded by Rhone-Poulenc Pharmaceuticals ($114,050). Role: Co-Investigator

Comparison Between the Use of NovolinPen and Syringe in the Treatment of Non-insulin Dependent Diabetes Mellitus. Funded by Squibb-Novo, Inc. ($19,125). Role: Co-Investigator.

A Long-Term, Multicenter Glycemic control Study in Outpatients with Insulin Independent (Non-Insulin Dependent - Type II) Diabetes Mellitus. A Randomized, Double-Blind Safety and Efficacy Comparison of PKG-A, PKG-B and Tolazamide. Funded by Pharmakinetic Laboratories, Inc. ($91,740). Role: Co-Investigator.

Lovastatin Dose-Ranging Multicenter Study in Patients with Type II Hypercholesterolemia, Total Cholesterol 240-300 mg/dl With or Without Evidence of Coronary Artery Disease. Funded by Merck and Company ($50,000). Role: Co-Investigator.

Evaluation of BW tPA in the Initial Lysis and Maintenance of Patency of Coronary Arteries in Patients with Acute Myocardial Infarction. Funded by Burroughs Wellcome Laboratories. Role: Co-Investigator.

An Open Trial of the Safety and Efficacy of Intravenous BW tPA in Patients with Acute Myocardial Infarction and Documented Coronary Artery Occlusion. Funded by Burroughs Wellcome Laboratories. Role: Co-Investigator.

Picenadol: Multicenter Dose Response in Postoperative Pain. Funded by Eli Lilly Corporation ($39,500). Role: Co-Investigator.

Protocol for the Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of TI 211-950 (Spirapril) in the Treatment of Hypertension. Funded by Sandoz Laboratories ($38,556). Role: Co-Investigator.

The Multicenter Evaluation of the Safety and Efficacy of Five Fixed Doses of Spirapril (TI 211-950) Administered Once-a-Day as Fixed Ascending Doses in the Treatment of Hypertension Compared to Placebo. Funded by Sandoz Laboratories ($49,500). Role: Co-Investigator.

Comparison of Naproxen Sodium and Naproxen sodium Plus codeine Sulfate in Patients with Moderate or Moderately Severe Pain Following Open Orthopedic Surgery of Hips and Shoulders. Funded by Syntex Laboratories ($14,091). Role: Co-Investigator

Therapeutic Drug Monitoring: Improved Performance and Cost Savings Through Pharmacy Intervention. Funded by Upjohn Laboratories ($1,500). Role: Co-PI.

Evaluation of Efficacy and Safety of Cilazapril in Combination with Hydrochlorothiazide in Patients with Essential Hypertension. Funded by Roche Laboratories ($45,885). Role: Co-Investigator.

Extended Long Term Treatment with Cilazapril in Patients with Essential Hypertension. Funded by Roche Laboratories ($9,000). Role: Co-Investigator.

Evaluation of the Efficacy and Safety of Cilazapril (Ro 312848) Versus Captopril in Patients with Essential Hypertension. Funded by Roche Laboratories ($36,659). Role: Co-Investigator.

Preliminary Studies for Utilizing Polymers as Chemical Carriers for 5-Aminosalicylic Acid in the Treatment of Inflammatory Bowel Disease. Funded by the West Virginia University Senate Committee on Research, Research Grants and Publications ($4,626). Role: Co-Investigator.


Comparison of the Effects of Several Nonsteroidal Anti-inflammatory Agents on Plasma Lithium Levels. Funded by Ciba-Geigy Pharmaceutical Company ($15,388). Role: Co-PI.

Sustained Lidocaine Levels Using Timed Bolus Administration. Funded by the American Heart Association ($4,105). Role: Co-PI.

Determination of the Pharmacokinetics and Clearance of Theophylline in Hypothyroid Patients. Funded by the West Virginia University Senate Committee on Research, Research Grants and Publications ($3,500). Role: Co-PI.

Pupillometry as a Pharmacological Probe of Receptor Sensitivity in Primary endogenous Depression. Funded in Part by a 1981 Roche Hospital Pharmacy Research Grant ($1,500). Role: Co-Investigator.

March 2014

james g. stevenson, pharm.d., bcps, fashp · curriculum vitae james g. stevenson, pharm.d. academic...

Documents